Pradžia › Širdies nepakankamumas › Arizona › Tucson

Širdies nepakankamumas klinikiniai tyrimai Tucson, AZ

10 tyrimai dėl Širdies nepakankamumas ieško dalyvių vietose Tucson ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

Renkami dalyviai

Banner - University Medical Center Tucson, Tucson

Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07214376

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Renkami dalyviai2 fazė

TMC Hlthcr Clin Res Office, Tucson
Pima Heart and Vascular, Tucson

Amžius nuo 40 iki 84 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06979362

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Renkami dalyviai3 fazė

Pima Heart and Vascular Clinical Research, Tucson

Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Renkami dalyviai3 fazė

Research Site, Tucson

Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT06677060

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Renkami dalyviai2 fazė

University of Arizona Sarver Heart Center, Tucson

Amžius nuo 40 iki 85 · Visoms lytims · Atnaujinta 2026-08-27 · NCT06793371

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Renkami dalyviaiStebimasis tyrimas

Pima Heart and Vascular, Tucson

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Renkami dalyviai3 fazė

Tenax Investigational Site, Tucson

Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-08-19 · NCT07288398

Alleviant ALLAY-HF Study

Renkami dalyviai

Pima Heart and Vascular, Tucson

Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT05685303

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Renkami dalyviai

Tucson Medical Center Health, Tucson
Banner University Tuscon, Tucson

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-13 · NCT03142152

Left vs Left Randomized Clinical Trial

Renkami dalyviai

University of Arizona College of Medicine- Phoenix, Tucson

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-02 · NCT05650658

Širdies nepakankamumas tyrimai kituose miestuose

Kiti tyrimai Tucson

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.